首页|期刊导航|中草药（英文版）|Challenges and opportunities for ginseng-based medicines in treating cardiac fibrosis from mechanistic insights to clinical translation

Challenges and opportunities for ginseng-based medicines in treating cardiac fibrosis from mechanistic insights to clinical translation

Mengtao Zhi Ao Wang Hailian Quan Lan Hong

中草药（英文版）2026，Vol.18Issue(3)：555-570,16.

中草药（英文版）2026，Vol.18Issue(3)：555-570,16.DOI:10.1016/j.chmed.2026.05.014

Challenges and opportunities for ginseng-based medicines in treating cardiac fibrosis from mechanistic insights to clinical translation

Mengtao Zhi ¹Ao Wang ²Hailian Quan ¹Lan Hong¹

作者信息

1. Department of Physiology and Pathophysiology,School of Medicine,Yanbian University,Yanji 133002,China
2. Pharmaceutical Experiment Teaching Center,College of Pharmacy,Yanbian University,Yanji 133002,China
折叠

摘要

关键词

cardiacfibrosis/extracellular matrix remodeling/ginseng/myofibroblast activation/Nrf2/Keap1 axis/quality markers/ROS-responsive nanoparticles/TGF-β signaling

Key words

cardiacfibrosis/extracellular matrix remodeling/ginseng/myofibroblast activation/Nrf2/Keap1 axis/quality markers/ROS-responsive nanoparticles/TGF-β signaling

引用本文复制引用

Mengtao Zhi,Ao Wang,Hailian Quan,Lan Hong..Challenges and opportunities for ginseng-based medicines in treating cardiac fibrosis from mechanistic insights to clinical translation[J].中草药（英文版）,2026,18(3):555-570,16.

基金项目

This work was financially supported by the National Natural Science Foundation of China(No.82360065). （No.82360065）

中草药（英文版）

ISSN：1674-6384

访问量0

下载量0

段落导航